Studying how daily changes, what you eat or drink, and exercise impact the measurement of body composition using a bioelectrical impedance analysis device
- Registration Number
- JPRN-UMIN000052512
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
1. Individuals with a pacemaker. 2. Patients with intravital metal or silicon implants. 3. Patients with poorly controlled circulatory problems despite medication or other treatments. 4. Those experiencing orthopedic problems resulting in regular physical pain. 5. Patients with preexisting neurological diseases. 6. Individuals experiencing joint pain in the lower limbs during exercise. 7. Pregnant individuals or those who may be pregnant. 8. Those with known food allergies to any substance to be ingested. 9. Individuals otherwise deemed unsuitable as subjects by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measures were skeletal muscle mass and body fat mass, obtained through multifrequency bioelectrical impedance analysis. Measurements were taken on each of the three experimental days at six-time points: immediately after the laboratory visit, post-experimental task (including water or food intake, or exercise), and at 30, 60, 90, and 120 minutes after the completion of the experimental task.
- Secondary Outcome Measures
Name Time Method Secondary outcomes encompass other body composition parameters such as body water content, mineral content, and protein content, as well as electrical resistance metrics including impedance, resistance, and phase angle, all obtained via multifrequency bioelectrical impedance analysis. Measurements will be conducted following the protocol outlined for the primary outcome. Additionally, age and gender will be recorded as general characteristics, and height and weight will be measured. Height will be assessed immediately after each experimental visit on all three experimental days, while weight will be measured in alignment with the primary outcome measurements.